Locoregional intravascular viral therapy of cancer: precision guidance for Paris's arrow?
Viral therapy of cancer includes strategies such as viral transduction of tumour cells with 'suicide genes', using viral infection to trigger immune-mediated tumour cell death and using oncolytic viruses for their direct anti-tumour action. However, problems still remain in terms of adequate viral delivery to tumours. A role is also emerging for single-organ isolation and perfusion. Having begun with the advent of isolated limb perfusion for extremity malignancy, experimental systems have been developed for the perfusion of other organs, particularly the liver, kidneys and lungs. These are beginning to be adopted into clinical treatment pathways. The combination of these two modalities is potentially significant. Locoregional perfusion increases the exposure of tumour cells to viral agents. In addition, the avoidance of systemic elimination through the immune and reticulo-endothelial systems should provide a mechanism for increased transduction/infection of target cells. The translation of laboratory research to clinical practice would occur within the context of perfusion programmes, which are already established in the clinic. Many of these programmes include the use of vasoactive cytokines such as tumour necrosis factor-alpha, which may have an effect on viral uptake. Evidence of activation of specific anti-tumour immunological responses by intratumoural and other existing methods of viral administration raises the intriguing possibility of a locoregional therapy, with the ability to affect distant sites of disease. In this review, we examined the state of the literature in this area and summarized current findings before indicating likely areas of continuing interest.
Pencavel
T
T
Targeted Therapy Team, The Institute of Cancer Research, and Sarcoma/Melanoma Unit, Royal Marsden Hospital, London, UK.
Seth
R
R
Hayes
A
A
Melcher
A
A
Pandha
H
H
Vile
R
R
Harrington
K J
KJ
D000818:Animals; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D009369:Neoplasms / Q000235:genetics / Q000628:therapy* / Q000821:virology; D050130:Oncolytic Virotherapy / Q000379:methods*; D050504:Oncolytic Viruses / Q000235:genetics / Q000502:physiology; D051381:Rats
J Vasc Interv Radiol. 2009 Jun;20(6):837-41
19465309
Br J Cancer. 2000 Feb;82(4):973-80
10732774
Liver Transpl. 2008 Dec;14(12):1708-17
19025921
Ann Surg Oncol. 2009 Feb;16(2):385-94
19034580
J Am Coll Surg. 2009 May;208(5):706-15; discussion 715-7
19476821
Hum Gene Ther. 2005 Apr;16(4):435-44
15871675
Anticancer Drugs. 2009 Jun;20(5):389-95
19287305
J Virol. 1985 Apr;54(1):92-7
3973985
Ann Surg. 2009 Jun;249(6):900-7
19474692
Curr Probl Cancer. 2009 May-Jun;33(3):168-93
19647615
Eur J Surg Oncol. 1988 Apr;14(2):157-63
3360157
Br J Cancer. 2000 Mar;82(5):1000-3
10737379
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2197-203
9815615
Cancer Res. 2005 May 15;65(10):4300-8
15899822
Gene Ther. 2008 Oct;15(20):1361-71
18480846
Cancer Chemother Pharmacol. 1999;43(1):35-42
9923539
Ann Surg Oncol. 2007 Feb;14(2):795-801
17096052
Cancer Treat Rev. 2004 Aug;30(5):425-36
15245775
Gene Ther. 2001 Nov;8(21):1618-26
11895000
Physiol Genomics. 2000 Apr 27;2(3):117-27
11015590
Cancer. 2006 Jan 1;106(1):156-62
16323177
Ann Oncol. 2009 Aug;20 Suppl 6:vi22-9
19617294
Anticancer Res. 2004 Jul-Aug;24(4):2295-301
15330175
J Clin Oncol. 2003 Oct 15;21(20):3737-43
14551293
Cancer Res. 2007 Jun 1;67(11):5345-53
17545615
Br J Surg. 1996 Apr;83(4):551-5
8665257
Cancer Res. 2010 Feb 1;70(3):875-82
20103634
Bull Cancer. 2009 Jan;96(1):103-9
19211365
Cancer J. 2004 Mar-Apr;10(2):128-38
15130272
Br J Cancer. 2002 Feb 1;86(3):436-42
11875712
Lancet Oncol. 2003 Jul;4(7):429-37
12850194
N Engl J Med. 1996 Dec 26;335(26):1950-5
8960474
Ann Surg Oncol. 2007 Jan;14(1):230-8
17066234
Surg Oncol. 2008 Sep;17(3):247-52
18556193
J Clin Oncol. 2009 Dec 20;27(36):6237-42
19917862
Clin Cancer Res. 2008 Feb 1;14(3):912-23
18245555
Eur J Surg Oncol. 1988 Apr;14(2):101-10
3360151
Cancer J. 2002 Mar-Apr;8(2):181-93
12004803
Biol Pharm Bull. 2006 Aug;29(8):1728-34
16880633
Gene Ther. 2009 Jan;16(1):78-92
18784747
Clin Cancer Res. 2007 Oct 15;13(20):5995-6000
17947460
Ann Surg. 1998 Dec;228(6):763-70
9860475
Hum Gene Ther. 2001 Mar 20;12(5):489-502
11268282
Mol Aspects Med. 2007 Feb;28(1):4-41
17306358
Mol Ther. 2007 Aug;15(8):1410-6
17505469
Gene Ther. 2005 Jun;12(12):958-64
15789062
BMJ. 2008 Apr 26;336(7650):902-3
18436919
Gene Ther. 1995 Mar;2(2):107-15
7719927
Ann Surg Oncol. 2008 Nov;15(11):3003-13
18509706
J Clin Oncol. 2001 Feb 15;19(4):1001-7
11181662
Mol Ther. 2007 Apr;15(4):651-9
17299401
Nat Med. 2008 Jan;14(1):37-44
18066076
Clin Cancer Res. 2009 Oct 1;15(19):6158-66
19773377
Cancer Chemother Pharmacol. 2009 Jan;63(2):321-30
18575868
J Surg Oncol. 2004 Oct 1;88(1):1-3
15384062
Ann Surg. 1995 Jan;221(1):29-42
7826158
Eur J Cancer. 2008 Dec;44(18):2726-36
19056036
Curr Opin Mol Ther. 2008 Aug;10(4):371-9
18683102
Eur J Surg Oncol. 2005 Oct;31(8):807-16
15951150
Gene Ther. 2007 Apr;14(8):671-81
17287860
Lancet. 2003 Feb 1;361(9355):368-73
12573372
Curr Opin Mol Ther. 2008 Aug;10(4):362-70
18683101
Br J Cancer. 1991 Dec;64(6):1069-75
1764369
Curr Opin Mol Ther. 2008 Feb;10(1):38-45
18228180
J Clin Oncol. 1992 Jan;10(1):52-60
1727926
Gene Ther. 2008 Jun;15(12):911-20
18323793
Clin Cancer Res. 2006 Dec 1;12(23):7108-16
17145835
Hum Gene Ther. 2000 Nov 20;11(17):2389-401
11096443
Clin Oncol (R Coll Radiol). 2002 Apr;14(2):148-69
12069125
Mol Ther. 2007 Sep;15(9):1686-93
17579581
Clin Cancer Res. 2009 Jan 15;15(2):561-9
19147761
Cancer Gene Ther. 2006 Feb;13(2):169-81
16082381
Gene Ther. 1997 Jan;4(1):55-62
9068796
Cancer Gene Ther. 2002 Dec;9(12):979-86
12522437
Ann Surg. 2000 Dec;232(6):814-21
11088076
Expert Rev Vaccines. 2009 Jan;8(1):51-66
19093773
J Clin Oncol. 2007 Mar 1;25(7):837-44
17327604
Gene Ther. 2010 Feb;17(2):158-70
20016540
Eur J Surg Oncol. 2006 May;32(4):371-80
16520016
Surgery. 2003 Apr;133(4):420-8
12717360
J Clin Oncol. 2002 Mar 15;20(6):1562-9
11896105
J Clin Oncol. 2001 Aug 15;19(16):3635-48
11504745
Surgery. 2001 Mar;129(3):324-34
11231461
Hum Gene Ther. 2006 Dec;17(12):1214-24
17107303
Cancer Res. 2002 Nov 1;62(21):6070-9
12414631
Ann Surg. 1958 Oct;148(4):616-32
13583933
J Clin Oncol. 1998 Sep;16(9):2906-12
9738557
J Gene Med. 2006 Jul;8(7):795-803
16652399
N Engl J Med. 2006 Jan 5;354(1):34-43
16394300
Hum Gene Ther. 2006 Jan;17(1):31-45
16409123